Home
About
Science
Pipeline
Clinical Trials
Partnerships
Investors
News

Investors | Financial Reports

Home InvestorsFinancial Reports

Investors | Financial Reports

Investors

Overview
The Share
Shareholder Information
Nomination Committee
Largest Shareholders
Financial Calendar
Events
Analyst Coverage
IR Contact
National Prospectus 2026

Loading latest reports...

Report PDF

Presentation PDF

Webcast

Title	Report	Presentation	Webcast
Interim – Q1 2026	—		—

Oncolytic Molecules that Kill Cancer with Direct & Abscopal Tumor Effects

Oslo, Norway

Company

About
Management Team
Board of Directors
Scientific Advisory Board

Science

Our Science
Pipeline
Publications
Posters

Resources

Clinical Trials
News & Events
Investor Relations

Connect

Partnerships
Contact

Partner With Us

© 2026 Lytix Biopharma ASA. All rights reserved.

Privacy PolicyTerms and Conditions Disclaimer